The Aspirin Foundation helps to increase awareness and medical research interest in this vitally important medicine by stimulating the distribution and exchange of information and discussion on all aspects of Aspirin, including current research as well as old and new therapeutic uses for it.
The Aspirin Foundation is guided by an independent International Scientific Advisory Board.
Entries open for the International Aspirin Foundation's Emerging Aspirin Investigator Award 2020
Deadline for applications : 31st May 2020
Supported by GL Pharma GmbH, the winning entrant will receive a £1000 endowment plus a travel and accommodation bursary.
A report will be produced to highlight the winning entry, together with a summary of the candidate’s work, and the successful applicant should be available to present their work during an Award Ceremony in London at the end of 2020.
Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention
Long term low- dose aspirin use in patients with chronic viral hepatitis reduces the risk of HCC and liver related mortality.